Development Level

Tchem 3 | 1,890
Tbio 1 | 10,625

IMPC Term

immune system phenotype 1 | 17

Disease

Cancer 4 | 2,346
Asthma 3 | 349
Waldenstrons macroglobulinemia 3 | 765
osteosarcoma 3 | 7,933
psoriasis 3 | 6,685
tuberculosis 3 | 1,557
Alzheimer's disease 2 | 644
Arthritis 2 | 248
Atherosclerosis 2 | 275
Cerebrovascular disease 2 | 231
Coronary artery disease 2 | 240
Crohn's disease 2 | 304
Hypersensitivity 2 | 63
Kidney disease 2 | 396
Lung disease 2 | 132
Multiple Sclerosis 2 | 498
Pneumonia 2 | 133
glioblastoma 2 | 5,572
ovarian cancer 2 | 8,484
pancreatic cancer 2 | 2,300
sarcoidosis 2 | 358
ulcerative colitis 2 | 2,087
Acquired immunodeficiency syndrome 1 | 164
Acute kidney injury 1 | 65
Age related macular degeneration 1 | 84
Anemia 1 | 252
Anoxia 1 | 33
Anxiety disorder 1 | 22
Arthritis, Experimental 1 | 39
Bladder Neoplasm 1 | 109
Brain Diseases 1 | 22
Brain Ischemia 1 | 87
Brain edema 1 | 26
Bronchitis 1 | 44
Carcinoma 1 | 2,147
Cardiovascular Diseases 1 | 50
Celiac disease 1 | 112
Cholestasis 1 | 93
Colitis 1 | 46
Common cold 1 | 63
Dermatitis, Allergic Contact 1 | 66
Diabetes Mellitus, Experimental 1 | 106
Diarrhea 1 | 155
Drug Eruptions 1 | 18
Drug-Induced Liver Injury 1 | 118
End Stage Liver Disease 1 | 4
Eosinophilia 1 | 65
Glomerulonephritis 1 | 36
Henoch-Schoenlein purpura 1 | 13
Hepatic encephalopathy 1 | 25
Hypersensitivity reaction type II disease 1 | 235
IGA Glomerulonephritis 1 | 454
Ileus 1 | 11
Infarction, Middle Cerebral Artery 1 | 25
Inflammation 1 | 109
Keratitis 1 | 42
Keratosis 1 | 34
Kidney Diseases 1 | 86
Liver carcinoma 1 | 217
Liver diseases 1 | 66
Lung Neoplasms 1 | 171
Lung diseases 1 | 48
Lupus erythematosus 1 | 80
Major Depressive Disorder 1 | 106
Mastitis 1 | 48
Neutropenia 1 | 78
Occupational Diseases 1 | 8
Pancreatitis 1 | 97
Periodontal disease 1 | 37
Peripheral Mobilization of Hematopoietic Stem Cells 1 | 2
Peripheral Neuropathy 1 | 303
Peritonitis 1 | 37
Pontocerebellar hypoplasia 1 | 29
Precancerous Conditions 1 | 69
Prostatic Neoplasms 1 | 471
Pulmonary Fibrosis 1 | 66
Purpura 1 | 17
Reperfusion Injury 1 | 84
Skin disease 1 | 65
Status Epilepticus 1 | 85
Toxic encephalopathy 1 | 131
Urticaria 1 | 53
Vasculitis 1 | 64
Wegener's granulomatosis 1 | 14
adult high grade glioma 1 | 2,148
astrocytoma 1 | 1,493
chronic kidney disease 1 | 90
cystic fibrosis 1 | 1,665
head and neck cancer 1 | 270
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 532
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
pancreatic carcinoma 1 | 567
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
posterior fossa group A ependymoma 1 | 1,511
sonic hedgehog group medulloblastoma 1 | 1,482
subependymal giant cell astrocytoma 1 | 2,287

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Urinary Tract 4 | 18,444
Skin and soft tissues 3 | 18,115

Target Family

Non-IDG 2 | 11,971
Enzyme 1 | 4,146
GPCR 1 | 406

Grant Application

5P01AR046798-03 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Putative peripheral benzodiazepine receptor-related protein TSPO Tbio Non-IDG -3.29377 2078.3 186
C-C chemokine receptor type 2 CCR2 Tchem GPCR -3.00281 1034.3 447
C-C motif chemokine 7 CCL7 Tchem Non-IDG -2.98750 994.3 377
Myeloperoxidase MPO Tchem Enzyme -3.46154 2949.2 1046